Vera Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.599; its P/E ratio is ―; Vera Therapeutics is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.81. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Income Statement	-
Total Revenue	$ 487.00K	$ 482.00K	$ 482.00K	$ 1.45M	-
Gross Profit	$ 487.00K	$ 482.00K	$ 482.00K	$ 482.00K	$ 482.00K
EBIT	$ -49.80M	$ -31.80M	$ -26.90M	$ -24.60M	$ -19.16M
EBITDA	$ -52.00M	$ -30.88M	$ -26.38M	$ -24.60M	$ -19.16M
Net Income Common Stockholders	$ -46.63M	$ -33.98M	$ -28.38M	$ -25.66M	$ -20.10M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 353.31M	$ 384.39M	$ 403.66M	$ 160.72M	$ 159.94M
Total Assets	$ 368.56M	$ 397.29M	$ 419.36M	$ 175.55M	$ 175.62M
Total Debt	$ 54.91M	$ 52.83M	$ 53.26M	$ 53.71M	$ 29.52M
Net Debt	$ -298.40M	$ -331.55M	$ -350.40M	$ -107.01M	$ -130.42M
Total Liabilities	$ 79.50M	$ 69.42M	$ 65.81M	$ 73.86M	$ 51.91M
Stockholders Equity	$ 289.06M	$ 327.87M	$ 353.54M	$ 101.69M	$ 123.71M
Cash Flow	-
Free Cash Flow	$ -37.12M	$ -24.87M	$ -33.83M	$ -25.21M	$ -22.97M
Operating Cash Flow	$ -36.88M	$ -24.78M	$ -33.83M	$ -25.14M	$ -22.97M
Investing Cash Flow	$ 38.32M	$ -22.68M	$ -219.29M	$ 18.56M	$ 16.23M
Financing Cash Flow	$ 739.00K	$ 3.44M	$ 276.54M	$ 24.83M	$ 297.00K

Currency in USD

Vera Therapeutics Earnings and Revenue History

Income Statement >

Vera Therapeutics Debt to Assets

Balance Sheet >

Vera Therapeutics Cash Flow

Cash Flow >

Vera Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing